INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 750 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 750 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 750 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 750 | -28.6% | 0.00% | – |
| Q4 2021 | $5,000 | -85.3% | 1,050 | -78.1% | 0.00% | – |
| Q3 2021 | $34,000 | -22.7% | 4,800 | 0.0% | 0.00% | – |
| Q2 2021 | $44,000 | -2.2% | 4,800 | -1.6% | 0.00% | – |
| Q1 2021 | $45,000 | -2.2% | 4,878 | -7.1% | 0.00% | – |
| Q4 2020 | $46,000 | +24.3% | 5,250 | +61.5% | 0.00% | – |
| Q3 2020 | $37,000 | -80.4% | 3,250 | -53.6% | 0.00% | -100.0% |
| Q2 2020 | $189,000 | +894.7% | 7,000 | +169.2% | 0.00% | – |
| Q1 2020 | $19,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |